Michael Gutknecht, PhD
Immunogenicity Profiling Expert
Biomedical Research Center
Novartis Pharma AG
Michael Gutknecht is a Principal Scientist II at Novartis Biomedical Research in Basel, Switzerland. His expertise is focused on pre-clinical immunogenicity assessment, biologics development, translational data science, and AI-enabled predictive modeling. His work focuses on building innovative computational tools and data products that transform complex immunogenicity data into actionable insights, enabling smarter decision-making across drug discovery and development.
At the Festival of Biologics Basel 2026, Michael will join fellow leaders and experts from across the biologics ecosystem to explore the scientific and operational advances shaping discovery, development, clinical trials, manufacturing, market access and fill & finish.